Etiometry 2025 Highlights and Looking Ahead to 2026

Blog

  • Delivered major platform advancements and expanded hospital adoption, informing the care of more than 425,000 patients to date.
  • Secured our 10th FDA clearance, validating enhanced cybersecurity protections for hospitals and patients.
  • Advanced the platform with deeper incorporation of high-resolution waveform data, enabling richer physiological insights at the point of care.
  • Earned the 2025 Digital Health Hub Award – Best in Class: AI in Patient Care at the HLTH conference.
  • Published a record number of clinical studies with leading institutions, strengthening evidence across pediatric and adult critical care.
  • Continued focus on our Cardiac Critical Care Solution, supporting clinicians by organizing and displaying patient data to aid decision-making in intensive care settings.
  • Added the highest number of hospitals in company history, with notable growth among major health systems.
  • Expanded internationally, strengthening our presence in Europe and the Middle East through strategic partnerships.

As Shane Cooke, President and CEO of Etiometry, noted, the platform plays a proven role in improving care quality, reducing length of stay and ICU readmissions, lowering costs, easing care team burden, and improving documentation of complications.


We are building on this momentum with a clear focus on:

  • Expanding our presence in the adult cardiac market.
  • Accelerating international expansion in Europe and the Middle East.
  • Continuing to advance solutions to help identify and manage life-threatening conditions, including cardiogenic shock, respiratory failure, and sepsis/ARDS.


Related

How Documentation, Length of Stay and Capacity Shape Cardiac Surgery Margins

What four years of CABG data from one cardiothoracic ICU suggest about each. Most patients recover from coronary artery bypass grafting along a familiar path: extubation, vasoactive weaning, transfer to the floor, discharge. For some, the postoperative course brings respiratory failure, acute kidney injury or cardiogenic shock. Those complications shape the patient’s recovery, and they […]

What Continuous Physiologic Data Reveals About Cardiogenic Shock

A retrospective analysis compared cardiogenic shock staging built from charted values with staging built from continuous data. The differences were clinically meaningful. In one patient’s record from the analysis, the chart shows a mean arterial pressure of 71 mmHg, and an hour later, 66 mmHg. Read on their own, the two values suggest a patient […]

When Cardiogenic Shock Goes Undocumented: The Clinical and Financial Cost

A missed or unrecorded diagnosis affects the patient first, and the hospital’s ability to care for the next patient soon after. In a busy cardiac ICU, cardiogenic shock is often managed before it is named. Pressors are titrated, labs are trended and the team responds to what the patient’s physiology is telling them. But the […]